Project Details
Projekt Print View

Characterization of autoantibodies targeting the cardiac repolarizing KCNQ1 potassium channel in a rabbit model.

Applicant Dr. Jin Li
Subject Area Cardiology, Angiology
Term from 2012 to 2013
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 231419723
 
Final Report Year 2014

Final Report Abstract

The cardiac voltage-gated KCNQ1 potassium channel plays a substantial role in ventricular repolarization and arrhythmogenesis. We developed an experimental autoimmune model against KCNQ1 in rabbits to study the electrophysiological effects of anti-KCNQl autoantibodies. Following immunization against KCNQ1, rabbits produced autoantibodies targeting the channel and infiltration of IgG within the myocardium was found. Consistent with results in a previously reported subgroup of patients with dilated cardiomyopathy and KCNQ1 autoantibodies that demonstrated QTc-interval shortening, KCNQl-immunized rabbits developed a shortened QTc interval. During in vivo electrophysiological study, we measured a reduced ventricular effective refractory period. Moreover, cardiomyocytes from KCNQl-immunized rabbits presented action potential duration abbreviation and /Ks potassium current enhancement providing direct experimental support for the presumed pathophysiology underlying the clinical observations. Cardiac function was not substantially affected by KCNQl-immunization as assessed by echocardiography. Histopathological staining of myocardial tissue showed no signs of inflammation or fibrosis thus further supporting the notion of a primary electrical pathomechanism rather than effects secondary to hemodynamic or structural remodeling. Finally, we investigated the therapeutic potential of vaccination against KCNQ1 in a rabbit LQT Syndrome model. KCNQl-immunization attenuated QTc interval prolongation induced by administration of the /Kr-blocker, dofetilide. This project is the first of which we are aware to provide evidence for therapeutic use of vaccination against cardiac ion channels to treat arrhythmias in susceptible patient subgroups.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung